Dendritic cell based immunotherapy in metastatic uveal melanoma

被引：0
|
作者：
Nesselhut, Jan
Marx, Dagmar
Chang, Raymond Y.
Nesselhut, Thomas
机构：
[1] Praxisgemeinschaft Zelltherapie, Duderstadt, Germany
[2] Meridian Medcal Grp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21526
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
    Sandra Van Lint
    Sofie Wilgenhof
    Carlo Heirman
    Jurgen Corthals
    Karine Breckpot
    Aude Bonehill
    Bart Neyns
    Kris Thielemans
    Cancer Immunology, Immunotherapy, 2014, 63 : 959 - 967
  • [42] Successful therapy of a metastatic uveal melanoma with tebentafusp after prior immunotherapy with ipilimumab and nivolumab
    Haalck, T.
    Burg, M. R.
    Heidrich, I.
    Heilberger, J.
    Hildebrandt, L.
    Kott, J.
    Wiltfang, L.
    Gebhardt, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 59 - 59
  • [43] Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma
    Bol, Kalijn F.
    Van den Bosch, Thomas
    Schreibelt, Gerty
    Mensink, Hanneke W.
    Keunen, Jan E. E.
    Kilic, Emine
    Japing, Wouter J.
    Geul, Kaspar W.
    Westdorp, Harm
    Boudewijns, Steve
    Croockewit, Sandra A. J.
    Van Rossum, Michelle M.
    De Goede, Anna L.
    Naus, Nicole C.
    Van der Graaf, Winette T. A.
    Gerritsen, Winald R.
    De Klein, Annelies
    Punt, Cornelis J. A.
    Figdor, Carl G.
    Cohen, Victoria M.
    Paridaens, Dion
    De Vries, I. Jolanda M.
    OPHTHALMOLOGY, 2016, 123 (10) : 2265 - +
  • [44] Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic Melanoma
    Uslu, Ugur
    Erdmann, Michael
    Schliep, Stefan
    Doerrie, Jan
    Schaft, Niels
    Schuler, Gerold
    Schuler-Thurner, Beatrice
    ANTICANCER RESEARCH, 2017, 37 (06) : 3243 - 3248
  • [45] Selecting uveal melanoma for PRAME-TCR T cell immunotherapy
    Jager, M. J.
    Krijgsman, D.
    Luyten, G. P. M.
    Luk, S. J.
    Van der Velden, P.
    Heemskerk, M. H. M.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [46] Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy
    Ribas, A
    Glaspy, JA
    Lee, YH
    Dissette, VB
    Seja, E
    Vu, HT
    Tchekmedyian, NS
    Oseguera, D
    Comin-Anduix, B
    Wargo, JA
    Amarnani, SN
    McBride, WH
    Economou, JS
    Butterfield, LH
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (05) : 354 - 367
  • [47] Therapy of metastatic malignant uveal melanoma
    Jäckel, A
    Bock, M
    Deichmann, M
    Waldmann, V
    Näher, H
    HAUTARZT, 2001, 52 (02): : 98 - 103
  • [48] Metastatic melanoma and immunotherapy
    Herzberg, Benjamin
    Fisher, David E.
    CLINICAL IMMUNOLOGY, 2016, 172 : 105 - 110
  • [49] Immunotherapy for metastatic melanoma
    Zito, Christopher R.
    Kluger, Harriet M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (03) : 725 - 734
  • [50] The genetic evolution of metastatic uveal melanoma
    A. Hunter Shain
    Mette M. Bagger
    Richard Yu
    Darwin Chang
    Shanshan Liu
    Swapna Vemula
    Jingly F. Weier
    Karin Wadt
    Steffen Heegaard
    Boris C. Bastian
    Jens F. Kiilgaard
    Nature Genetics, 2019, 51 : 1123 - 1130
12345